Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MMSI 
Merit Medical Systems Inc (MMSI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: MMSI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $103.55
1 Year Target Price $103.55
| 4 | Strong Buy |
| 5 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 33.43% | Avg. Invested days 61 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.05B USD | Price to earnings Ratio 43.26 | 1Y Target Price 103.55 |
Price to earnings Ratio 43.26 | 1Y Target Price 103.55 | ||
Volume (30-day avg) 10 | Beta 0.66 | 52 Weeks Range 81.04 - 111.45 | Updated Date 08/15/2025 |
52 Weeks Range 81.04 - 111.45 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.97 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-30 | When Before Market | Estimate 0.8475 | Actual 1.01 |
Profitability
Profit Margin 8.31% | Operating Margin (TTM) 12.3% |
Management Effectiveness
Return on Assets (TTM) 4.19% | Return on Equity (TTM) 8.6% |
Valuation
Trailing PE 43.26 | Forward PE 25.32 | Enterprise Value 5525387150 | Price to Sales(TTM) 3.52 |
Enterprise Value 5525387150 | Price to Sales(TTM) 3.52 | ||
Enterprise Value to Revenue 3.86 | Enterprise Value to EBITDA 18 | Shares Outstanding 59219100 | Shares Floating 57823915 |
Shares Outstanding 59219100 | Shares Floating 57823915 | ||
Percent Insiders 2.23 | Percent Institutions 106.53 |
Upturn AI SWOT
Merit Medical Systems Inc
Company Overview
History and Background
Merit Medical Systems, Inc. was founded in 1987 by Fred P. Lampropoulos. The company initially focused on developing and manufacturing disposable products for cardiology and radiology. Over the years, Merit Medical has grown through organic growth and strategic acquisitions, expanding its product portfolio and global reach.
Core Business Areas
- Cardiovascular: Develops and manufactures devices used in diagnostic and interventional cardiology procedures, including angiography, angioplasty, and stenting.
- Interventional Oncology and Critical Care: Provides products for interventional oncology procedures, such as tumor ablation and embolization, as well as devices for critical care applications, including central venous catheters and pressure monitoring systems.
- Peripheral Intervention: Offers products for the treatment of peripheral vascular disease, including catheters, guidewires, and balloons.
- Endoscopy: Provides products for endoscopic retrograde cholangiopancreatography (ERCP) and other endoscopic procedures.
Leadership and Structure
Fred P. Lampropoulos serves as the Chairman and CEO. The company has a typical corporate structure with executive leadership overseeing various departments, including sales, marketing, research and development, and operations.
Top Products and Market Share
Key Offerings
- EmboSphere Microspheres: Used for selective internal radiation therapy (SIRT) in the treatment of liver cancer. Market share is estimated to be significant in the SIRT microsphere market. Competitors include Boston Scientific, Sirtex Medical, and BTG (now Boston Scientific).
- Prelude Introducer Sheath: Used to facilitate the introduction of catheters and other devices into blood vessels. Holds a significant market share in the introducer sheath market. Competitors include Terumo Medical Corporation, Cook Medical, and Medtronic.
- Concerto ONYX Detachable Tip Microcatheter: A microcatheter used for neurovascular procedures. Growing market presence in the neurovascular access device segment. Competitors include MicroVention, Stryker, and Penumbra.
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulatory scrutiny, and increasing demand driven by an aging population and prevalence of chronic diseases. The interventional cardiology and radiology segments are growing due to minimally invasive procedures. There is a significant trend of consolidation.
Positioning
Merit Medical is positioned as a developer and manufacturer of niche interventional and diagnostic medical devices. The company's competitive advantages include a diversified product portfolio, strong customer relationships, and a focus on innovation.
Total Addressable Market (TAM)
TAM for Merit Medical's core markets is estimated to be in the billions of dollars. Merit Medical is positioned to capture a larger share through product innovation, strategic acquisitions, and geographic expansion.
Upturn SWOT Analysis
Strengths
- Diversified product portfolio
- Strong customer relationships
- Focus on innovation
- Experienced management team
- Global distribution network
Weaknesses
- Reliance on key suppliers
- Exposure to currency fluctuations
- Limited brand recognition compared to larger competitors
- Potential for product liability claims
- High debt levels
Opportunities
- Expanding into emerging markets
- Developing new products and technologies
- Acquiring complementary businesses
- Increasing adoption of minimally invasive procedures
- Capitalizing on demographic trends
Threats
- Increased competition
- Regulatory changes
- Economic downturns
- Technological obsolescence
- Healthcare cost containment pressures
Competitors and Market Share
Key Competitors
- BSX
- MDT
- JNJ
Competitive Landscape
Merit Medical competes with larger, more established medical device companies. Merit's advantages include a focused product portfolio and strong customer relationships. Disadvantages include smaller scale and limited brand recognition compared to its main competitors.
Major Acquisitions
BD Peripheral Intervention
- Year: 2023
- Acquisition Price (USD millions): 200
- Strategic Rationale: This acquisition expands Merit Medical's product portfolio in peripheral intervention and provides access to new markets and customers.
CardioSphere
- Year: 2020
- Acquisition Price (USD millions): 65
- Strategic Rationale: Strengthened Merit's product offerings in cardiovascular diagnostics and treatment.
Growth Trajectory and Initiatives
Historical Growth: Merit Medical has experienced growth through a combination of organic expansion and acquisitions.
Future Projections: Analysts project continued revenue growth driven by new product launches and market expansion.
Recent Initiatives: Recent strategic initiatives include acquisitions of companies with complementary technologies, expansion into new geographic markets, and increased investment in research and development.
Summary
Merit Medical is a mid-sized medical device company with a diverse product portfolio and a history of growth through acquisitions. The company is well-positioned in the interventional cardiology and radiology markets, but faces competition from larger players. Recent acquisitions should drive future growth, but high debt levels and regulatory changes remain as concerns.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10-K, 10-Q)
- Investor presentations
- Analyst reports
- Industry publications
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Investment decisions should be made based on individual circumstances and with the assistance of a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Merit Medical Systems Inc
Exchange NASDAQ | Headquaters South Jordan, UT, United States | ||
IPO Launch date 1990-08-09 | President & CEO Ms. Martha Goldberg Aronson | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 7400 | Website https://www.merit.com |
Full time employees 7400 | Website https://www.merit.com | ||
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.